GlassScriptPhysician profile
Devang P Desai
NPI 1881696342
$1,438.60
in general payments reported to CMS, 2019-2025
16 companies · $887 in 2025
The $887 reported for 2025 was more than what 77% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.66 · 2023: $96.47 · 2024: $432 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $570.60 | 2024-2025 | |
| Medtronic, INC. | $214.67 | 2023-2025 | Propel, Azure Xt Dr Mri Surescan |
| Regeneron Healthcare Solutions, INC. | $204.55 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $104.29 | 2024-2025 | Nucala |
| Depuy Synthes Sales INC. | $63.29 | 2024-2025 | Matrixmandible, Matrixmidface, Trumatch |
| Optinose US, INC. | $48.13 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $46.76 | 2025 | Neffy |
| Lilly USA, LLC | $26.68 | 2025 | Zepbound |
| Phadia US INC. | $24.06 | 2024 | Immunocap |
| Paratek Pharmaceuticals, INC. | $23.95 | 2025 | Xhance |
| Olympus America INC. | $23.66 | 2020 | |
| Inspire Medical Systems, INC. | $22.86 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $18.92 | 2024 | Xarelto |
| Fisher & Paykel Healthcare INC | $17.44 | 2023 | Fisher & Paykel Healthcare |
| Alk-Abello, INC | $14.90 | 2025 | Grastek, Odactra, Ragwitek |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $13.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devang Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.